Asparaginase (Merck Sharp & Dohme/Lundbeck)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAsparaginase (Merck Sharp & Dohme/Lundbeck)
Drug Alias Name门冬酰胺酶Elspar
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzyme
Mechanisms of ActionAspartate-ammonia ligase inhibitorsAmidohydrolases stimulantsAsparagine inhibitors
TargetsAspartate-ammonia ligaseAmidohydrolasesAsparagine
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1978/01/10
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/SMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeL01XX02
Related LinksN/A